Analysis of JNK, Mdm2 and p14(ARF) contribution to the regulation of mutant p53 stability.
暂无分享,去创建一个
V. Adler | Z. Ronai | T. Buschmann | S. Fuchs | T. Minamoto | N. Wagle | M. Mai | N. Wagle | Serge Y. Fuchs | V. Adler | Masyoshi Mai
[1] A. Fersht,et al. Mutually compensatory mutations during evolution of the tetramerization domain of tumor suppressor p53 lead to impaired hetero-oligomerization. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[2] H. Zentgraf,et al. Characterization of sequence elements involved in p53 stability regulation reveals cell type dependence for p53 degradation , 1998, Oncogene.
[3] D. Livingston,et al. p300/MDM2 complexes participate in MDM2-mediated p53 degradation. , 1998, Molecular cell.
[4] M. Kubbutat,et al. Regulation of Mdm2-Directed Degradation by the C Terminus of p53 , 1998, Molecular and Cellular Biology.
[5] Y Taya,et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. , 1998, Science.
[6] V. Adler,et al. JNK targets p53 ubiquitination and degradation in nonstressed cells. , 1998, Genes & development.
[7] F. Zindy,et al. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[8] S. Deb,et al. `Gain of function' phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domain , 1998, Oncogene.
[9] T. Fojo,et al. p53 Inhibits Hypoxia-inducible Factor-stimulated Transcription* , 1998, The Journal of Biological Chemistry.
[10] K. Aldape,et al. An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[11] Ken Chen,et al. The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53 , 1998, Cell.
[12] Yue Xiong,et al. ARF Promotes MDM2 Degradation and Stabilizes p53: ARF-INK4a Locus Deletion Impairs Both the Rb and p53 Tumor Suppression Pathways , 1998, Cell.
[13] P. Howley,et al. The Role of E6AP in the Regulation of p53 Protein Levels in Human Papillomavirus (HPV)-positive and HPV-negative Cells* , 1998, The Journal of Biological Chemistry.
[14] A. Fersht,et al. Thermodynamic stability of wild-type and mutant p53 core domain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. C. Hu,et al. JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinases , 1997, Oncogene.
[16] Yoichi Taya,et al. DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.
[17] D. Lane,et al. p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding , 1997, Oncogene.
[18] M. Oren,et al. Mdm2 promotes the rapid degradation of p53 , 1997, Nature.
[19] Stephen N. Jones,et al. Regulation of p53 stability by Mdm2 , 1997, Nature.
[20] L. Bracco,et al. Proteolysis by calpains: a possible contribution to degradation of p53 , 1997, Molecular and cellular biology.
[21] P. Branton,et al. Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells , 1997, Journal of virology.
[22] M. Pagano,et al. Mechanism of p53 degradation. , 1997, Biochimica et biophysica acta.
[23] M. Pincus,et al. Conformation-dependent phosphorylation of p53. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[24] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[25] M. Kubbutat,et al. Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability , 1997, Molecular and cellular biology.
[26] C. Prives,et al. p53: puzzle and paradigm. , 1996, Genes & development.
[27] A. Fornace,et al. The two faces of tumor suppressor p53. , 1996, The American journal of pathology.
[28] T. Crook,et al. Sensitivity of p53 lysine mutants to ubiquitin-directed degradation targeted by human papillomavirus E6. , 1996, Virology.
[29] W. Deppert,et al. Cooperation of simian virus 40 large and small T antigens in metabolic stabilization of tumor suppressor p53 during cellular transformation , 1995, Journal of virology.
[30] D. Haber,et al. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. , 1995, Genes & development.
[31] D. Meek,et al. p53 Is Phosphorylated in Vitro and in Vivo by an Ultraviolet Radiation-induced Protein Kinase Characteristic of the c-Jun Kinase, JNK1 (*) , 1995, The Journal of Biological Chemistry.
[32] M. Oren,et al. Biochemical properties and biological effects of p53. , 1995, Current opinion in genetics & development.
[33] L. Donehower,et al. The tumore suppressor p53 , 1993 .
[34] A. Levine,et al. The p53-mdm-2 autoregulatory feedback loop. , 1993, Genes & development.
[35] Amy Bernard,et al. Physical and functional interaction between WT1 and p53 proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[36] A. Levine,et al. Gain of function mutations in p53 , 1993, Nature Genetics.
[37] B. Vogelstein,et al. Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.
[38] M. Scheffner,et al. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. , 1991, The EMBO journal.
[39] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[40] A. Levine,et al. The p53 tumour suppressor gene , 1991, Nature.
[41] Arnold J. Levine,et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.
[42] C. Anderson,et al. Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen , 1990, Molecular and cellular biology.
[43] W. Maltzman,et al. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells , 1984, Molecular and cellular biology.